RESUMO

The type II transmembrane glycoprotein CD38 has recently been implicated in regulating metabolism and the pathogenesis of multiple conditions, including aging, inflammation and cancer. CD38 is overexpressed in several tumor cells and microenvironment tumoral cells, associated to migration, angiogenesis, cell invasion and progression of the disease. Thus, CD38 has been used as a progression marker for different cancer types as well as in immunotherapy. This review focuses on describing the involvement of CD38 in various non-hematopoietic cancers.

Assuntos

Imunoterapia , Neoplasias , ADP-Ribosil Ciclase 1/metabolismo , Biomarcadores , Humanos , Fatores Imunológicos , Neoplasias/terapia , Microambiente Tumoral